Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age

Clinical trial NCT00242424 · COMPLETED

Trial details

NCT number: NCT00242424
Sponsor: Seattle Children's Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Inactivated Influenza Vaccine

Start date: 2005-09-01
Primary completion: 2006-09-01
Enrollment: 1375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.